X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-12 | JSPR | Mahal Jeetinder Singh | COO | S - Sale+OE | $21.23 | -900 | 25,009 | -3% | -$19,104 | |||||
| D | 2024-06-12 | JSPR | Mahal Jeetinder Singh | COO | S - Sale+OE | $24.16 | -900 | 25,009 | -3% | -$21,740 | |||||
| D | 2024-03-12 | JSPR | Mahal Jeetinder Singh | COO | S - Sale+OE | $26.44 | -900 | 25,009 | -3% | -$23,792 | |||||
2024-02-08 | JSPR | Carlyle Group Inc. | Former 10% owner | P - Purchase | $12.95 | +190,000 | 1,066,189 | +22% | +$2,460,500 | ||||||
2024-02-08 | JSPR | Velan Capital Investment Management LP | 10% | P - Purchase | $12.95 | +350,000 | 1,433,828 | +32% | +$4,532,500 | ||||||
2023-11-28 | JSPR | Wiggans Thomas G | Dir | P - Purchase | $0.65 | +10,000 | 50,000 | +25% | +$6,486 | ||||||
2023-11-21 | JSPR | Wiggans Thomas G | Dir | P - Purchase | $0.64 | +10,000 | 40,000 | +33% | +$6,383 | ||||||
| M | 2023-11-16 | JSPR | Wiggans Thomas G | Dir | P - Purchase | $0.61 | +30,000 | 30,000 | New | +$18,240 | |||||
2023-10-13 | JSPR | Lis William | Dir | S - Sale | $0.85 | -7,965 | 53,521 | -13% | -$6,777 | ||||||
| D | 2023-06-13 | JSPR | Mahal Jeetinder Singh | See Remarks | S - Sale+OE | $1.66 | -9,000 | 287,223 | -3% | -$14,915 | |||||
2023-04-14 | JSPR | French Anna Louise | Dir | S - Sale | $1.48 | -7,000 | 23,750 | -23% | -$10,360 | ||||||
2023-04-13 | JSPR | Emster Kurt Von | Dir | S - Sale | $1.49 | -9,075 | 21,175 | -30% | -$13,524 | ||||||
2023-04-13 | JSPR | Lis William | Dir | S - Sale | $1.44 | -8,500 | 61,486 | -12% | -$12,240 | ||||||
2023-01-27 | JSPR | Qiming U.S. Healthcare Fund Ii, L.P. | 10% | P - Purchase | $1.50 | +2,666,666 | 8,519,648 | +46% | +$3,999,999 | ||||||
2023-01-27 | JSPR | Carlyle Group Inc. | 10% | P - Purchase | $1.50 | +3,133,333 | 8,761,891 | +56% | +$4,700,000 | ||||||
2023-01-25 | JSPR | Roche Holding Ltd | 10% | S - Sale | $1.89 | -75,000 | 4,549,606 | -2% | -$141,750 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |